Esperion Therapeutics Inc (ESPR)

Aug 20, 2025

Esperion rises after revenue beat, Q1 profitability expectation - MSN

Aug 20, 2025

Aug 19, 2025

Three Analyst Favorites with Potential for Further Gains: SkyWater Technology, Emergent BioSolutions, and More - AInvest

Aug 19, 2025

Aug 18, 2025

Detecting support and resistance levels for Esperion Therapeutics Inc.Stock Surge & Safe Entry Momentum Tips - Newser

Aug 18, 2025

Aug 18, 2025

Chart based analysis of Esperion Therapeutics Inc. trendsWeekly Market Report & AI Forecasted Entry/Exit Points - Newser

Aug 18, 2025

Aug 18, 2025

Is Esperion Therapeutics Inc. still worth holding after the dip2025 Short Interest & Community Consensus Picks - Newser

Aug 18, 2025

Aug 18, 2025

Esperion Therapeutics soars amid vague takeover speculation - MSN

Aug 18, 2025

Aug 17, 2025

Best data tools to analyze Esperion Therapeutics Inc. stockTrade Risk Report & Risk Controlled Daily Plans - Newser

Aug 17, 2025

Aug 17, 2025

Esperion Therapeutics Inc. stock outlook for YEARPortfolio Update Report & Stepwise Entry/Exit Trade Alerts - Newser

Aug 17, 2025

Aug 17, 2025

Is Esperion Therapeutics Inc. a Top Dividend Stock to Watch in 2025Market Movers & AI Based Trade Execution Alerts - Newser

Aug 17, 2025

Aug 17, 2025

Applying sector rotation models to Esperion Therapeutics Inc.Market Growth Summary & Free Low Drawdown Momentum Trade Ideas - Newser

Aug 17, 2025

Aug 17, 2025

Esperion Therapeutics (NASDAQ:ESPR) Upgraded at Wall Street Zen - Defense World

Aug 17, 2025

Aug 17, 2025

Pattern recognition hints at Esperion Therapeutics Inc. upsideStock Surge & Risk Adjusted Buy/Sell Alerts - Newser

Aug 17, 2025

Aug 16, 2025

What MACD signals say about Esperion Therapeutics Inc.July 2025 PostEarnings & Step-by-Step Swing Trade Plans - Newser

Aug 16, 2025

Aug 16, 2025

Real time scanner hits for Esperion Therapeutics Inc. explainedJuly 2025 Earnings & Smart Money Movement Alerts - Newser

Aug 16, 2025

Aug 16, 2025

Will Esperion Therapeutics Inc. price bounce be sustainableCEO Change & Daily Market Momentum Tracking - Newser

Aug 16, 2025

Aug 16, 2025

What the charts say about Esperion Therapeutics Inc. today2025 Price Targets & Long Hold Capital Preservation Tips - Newser

Aug 16, 2025

Aug 15, 2025

Is Esperion Therapeutics Inc. stock poised for growth2025 EndofYear Setup & Stock Portfolio Risk Control - Newser

Aug 15, 2025

Aug 15, 2025

Backtesting results for Esperion Therapeutics Inc. trading strategiesWeekly Gains Summary & Breakout Confirmation Trade Signals - Newser

Aug 15, 2025

Aug 15, 2025

Assessing Madrigal Pharmaceuticals' Long-Term Market Potential in the LDL-C Lowering Therapy Sector Amid Competitive Dynamics - AInvest

Aug 15, 2025

Aug 15, 2025

Is a relief rally coming for Esperion Therapeutics Inc. holdersDollar Strength & Free High Accuracy Swing Entry Alerts - Newser

Aug 15, 2025

Aug 14, 2025

Signal strength of Esperion Therapeutics Inc. stock in tech scannersJuly 2025 Update & Short-Term Trading Opportunity Alerts - Newser

Aug 14, 2025

Aug 14, 2025

Can Esperion Therapeutics Inc. Regain Momentum After BreakdownJuly 2025 Rallies & Safe Entry Trade Reports - beatles.ru

Aug 14, 2025

Aug 13, 2025

What earnings revisions data tells us about Esperion Therapeutics Inc.Quarterly Profit Review & Real-Time Buy Signal Notifications - Newser

Aug 13, 2025

Aug 13, 2025

Wall Street Zen Upgrades Esperion Therapeutics (NASDAQ:ESPR) to "Hold" - MarketBeat

Aug 13, 2025

Aug 12, 2025

Esperion Delays Q2 2025 Financial Report Filing - MSN

Aug 12, 2025

Aug 12, 2025

Competitive Positioning of Esperion Therapeutics Inc.: Is It Leading or LaggingFree Intraday Trend Analysis for Fast Gains - Newser

Aug 12, 2025

Aug 10, 2025

Published on: 2025-08-10 18:32:11 - beatles.ru

Aug 10, 2025

Aug 10, 2025

FY2025 EPS Estimates for ESPR Boosted by Cantor Fitzgerald - Defense World

Aug 10, 2025

Aug 09, 2025

Esperion Therapeutics Inc. At Decision Level — Rebound or ResistanceExpert Verified Stock Trade Ideas Backed by Data - beatles.ru

Aug 09, 2025

Aug 09, 2025

ESPR's Q2 Earnings & Revenues Trump Estimates, Stock Rises - MSN

Aug 09, 2025

Aug 09, 2025

Esperion Therapeutics (NASDAQ:ESPR) Upgraded to Hold at Wall Street Zen - Defense World

Aug 09, 2025

Aug 09, 2025

HC Wainwright Issues Positive Outlook for ESPR Earnings - Defense World

Aug 09, 2025

Aug 08, 2025

Published on: 2025-08-08 10:01:24 - beatles.ru

Aug 08, 2025

Aug 07, 2025

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) for New Employees - AInvest

Aug 07, 2025

Aug 07, 2025

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

Aug 07, 2025

Aug 07, 2025

Esperion Grants 73,500 RSUs with 4-Year Vesting Schedule to Attract Top Talent - Stock Titan

Aug 07, 2025

Aug 06, 2025

Esperion Therapeutics’ Earnings Call Highlights Growth - The Globe and Mail

Aug 06, 2025

Aug 06, 2025

Esperion (ESPR) Q2 Revenue Jumps 12% - AOL.com

Aug 06, 2025

Aug 06, 2025

Esperion Therapeutics (ESPR) Reports Q2 Loss, Tops Revenue Estimates - MSN

Aug 06, 2025

Aug 06, 2025

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 06, 2025

Aug 06, 2025

Esperion expects sustainable profitability in Q1 2026 as double-digit growth continues - MSN

Aug 06, 2025

Aug 06, 2025

Esperion Therapeutics: Q2 Earnings Snapshot - New Haven Register

Aug 06, 2025

Aug 06, 2025

What institutional flow reveals about Esperion Therapeutics Inc.Long-Term Stock Growth Forecast Insights - Newser

Aug 06, 2025

Aug 06, 2025

Esperion Therapeutics Inc (ESPR) Q2 2025 Earnings Call Highlights: Strong US Net Product ... By GuruFocus - Investing.com Canada

Aug 06, 2025

Aug 06, 2025

Esperion Therapeutics Reports Strong Q2 2025 Growth - TipRanks

Aug 06, 2025